ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

ANALYSIS OF EFFECTS OF ATTITUDE TO DISEASE ON QUALITY OF LIFE IN PATIENTS WITH BONE TUMORS

AUTHORS:

Dr Hassam Ahmed, Dr Zainab Nadeem, Dr Hasnain Aslam

ABSTRACT:

Introduction: Patients with advanced cancer exist in a unique medical context in which they are facing mortality and may be considering treatment options that have significant potential for toxicity. In addition, therapeutic choices are characterized by uncertain outcomes, and may be varied and complex, including supportive care alone, standard treatments (e.g. chemotherapy, radiation, biologic), and investigational approaches. Aims and objectives: The basic aim of the study is to analyze the effects of attitude to disease on quality of life in patients with bone tumors in Pakistan. Methodology of the study: This study was conducted in Shifa College of Medicine, Islamabad and BHU Dagger Qureshi, Bhakkar during 2018. This study was done for the analysis of quality of life of bone tumor patients in Pakistan. The data were collected through a prepared questionnaire. Participants using the secure website to complete the survey signed informed consent documents electronically. All participants provided written consent upon arrival for their physician appointments. Results: The data were collected from 100 patients of both genders. To develop the propensity score model, we used a multinomial logistic regression of the nominal three-category quality of life variable. The age, SF-12, education, sex, and race terms were entered into the model using restricted cubic splines for age, SF-12 PCS, and SF-12 MCS and interactions of sex with age and education. Conclusion: It is concluded that patients with less cancer-related distress were more likely to favor quality of life over length of life. The direction of causation in this relationship cannot be inferred from these data.

FULL TEXT

Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.